Noah M. Hahn, M.D.

Member, Clinical Advisory Board

Dr. Hahn is Director of the Medical Oncology Bladder Cancer Program and Associate Professor of Oncology and Urology at the Johns Hopkins University School of Medicine. He is an internationally recognized authority in the conduct of bladder cancer novel therapeutic clinical trials and translational investigations, and one of the few oncologists in the world leading a clinical trial in non-muscle invasive bladder cancer. After graduating from the University of Notre Dame with a degree in mechanical engineering, he earned his M.D. degree in 2000 at the Indiana University School of Medicine. He completed an internship at Emory University, internal medicine residency at Duke University, and an hematology and oncology fellowship at the Indiana University Simon Cancer Center (IUSCC). He then joined the IUSCC oncology faculty and served as the leader of its prostate and bladder cancer programs. Dr. Hahn joined Johns Hopkins in 2014. He also serves as bladder cancer chairman of the Eastern Cooperative Oncology Group (ECOG), co-chairs the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, participates on the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.